Answers are grounded in this paper and cite their sources.
SUMMARY Although antibody‐dependent platelet transfusion refractoriness has become less frequent with the introduction of leukocyte filtration of platelet concentrates, it remains a challenge in transfusion medicine. Small transfusion centers do not have easy access to an inventory of human leukocyte antigen (HLA)‐typed platelet donors. As flow cytometry has become more common, this technology can easily be introduced in platelet crossmatching, with sensitivity and predictive values comparable to those of other techniques, and with the advantage of automation. An algorithm is presented for use of flow cytometry in the selection of compatible platelets for alloimmunized patients.
No takes yet. Share an insight, caveat, or question.
Skogen et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: